全文获取类型
收费全文 | 9037篇 |
免费 | 709篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 249篇 |
妇产科学 | 55篇 |
基础医学 | 1173篇 |
口腔科学 | 176篇 |
临床医学 | 943篇 |
内科学 | 1862篇 |
皮肤病学 | 147篇 |
神经病学 | 1192篇 |
特种医学 | 682篇 |
外科学 | 1599篇 |
综合类 | 47篇 |
一般理论 | 4篇 |
预防医学 | 435篇 |
眼科学 | 157篇 |
药学 | 419篇 |
中国医学 | 6篇 |
肿瘤学 | 571篇 |
出版年
2024年 | 17篇 |
2023年 | 116篇 |
2022年 | 171篇 |
2021年 | 387篇 |
2020年 | 245篇 |
2019年 | 288篇 |
2018年 | 329篇 |
2017年 | 290篇 |
2016年 | 360篇 |
2015年 | 351篇 |
2014年 | 468篇 |
2013年 | 554篇 |
2012年 | 841篇 |
2011年 | 829篇 |
2010年 | 467篇 |
2009年 | 391篇 |
2008年 | 591篇 |
2007年 | 586篇 |
2006年 | 488篇 |
2005年 | 368篇 |
2004年 | 337篇 |
2003年 | 290篇 |
2002年 | 283篇 |
2001年 | 88篇 |
2000年 | 59篇 |
1999年 | 66篇 |
1998年 | 46篇 |
1997年 | 21篇 |
1996年 | 23篇 |
1995年 | 19篇 |
1994年 | 16篇 |
1993年 | 18篇 |
1992年 | 39篇 |
1991年 | 28篇 |
1990年 | 32篇 |
1989年 | 27篇 |
1988年 | 26篇 |
1987年 | 26篇 |
1986年 | 15篇 |
1985年 | 20篇 |
1984年 | 8篇 |
1983年 | 12篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1979年 | 11篇 |
1978年 | 14篇 |
1976年 | 11篇 |
1973年 | 10篇 |
1972年 | 12篇 |
1922年 | 14篇 |
排序方式: 共有9790条查询结果,搜索用时 15 毫秒
101.
In vivo evaluation of biofunctionalized implant surfaces with a synthetic peptide (P‐15) and its impact on osseointegration. A preclinical animal study 下载免费PDF全文
102.
Ilaria Callegari Tobias Derfuss Edoardo Galli 《Presse medicale (Paris, France : 1983)》2021,50(2):104068
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. In recent years, many disease-modifying therapies (DMT) have been approved for MS treatment. For this reason, a profound knowledge of the characteristics and indications of the available compounds is required to tailor the therapeutic strategy to the individual patient characteristics. This should include the mechanism of action and pharmacokinetic of the drug, the safety and efficacy profile provided by clinical trials, as well as the understanding of possible side effects. Moreover, the evolving knowledge of the disease is paving the way to new and innovative therapeutic approaches, as well as the development of new biomarkers to monitor the therapeutic response and to guide the clinician's therapeutic choices. In this review we provide a comprehensive overview on currently approved therapies in MS and the emerging evidence-based strategies to adopt for initiating, monitoring, and eventually adapting a therapeutic regimen with DMT. 相似文献
103.
Matthias Aurich Patrick Fuchs Matthias Müller-Hennessen Lorenz Uhlmann Matthias Niemers Sebastian Greiner Tobias Täger Kristof Hirschberg Philipp Ehlermann Benjamin Meder Lutz Frankenstein Evangelos Giannitsis Hugo A. Katus Derliz Mereles 《Journal of the American Society of Echocardiography》2018,31(6):733-742
104.
105.
106.
Annika Kathrin Steingräber Sonja Schelhaas Andreas Faust Andreas Hans Jacobs Michael Schäfers Tobias Goerge 《Experimental dermatology》2013,22(11):730-735
Matrix metalloproteinases (MMPs) play a critical role in various pathological conditions including cutaneous inflammation. Thus far, serial assessment of MMP activity in ongoing inflammation is hampered due to technical limitations. Here, we present an innovative method for longitudinal detection of MMP activity by in vivo imaging. First, we analysed skin sections from patients suffering from leucocytoclastic vasculitis (LcV) and detected a significant MMP signal via immunofluorescence staining. Then, we mimicked LcV in mice in a well‐studied model of immune complex‐mediated vasculitis (ICV). This acute inflammatory process was serially visualized in vivo using the fluorescence‐labelled MMP tracer Cy5.5‐AF443. The deposition of fluorescence‐labelled immune complexes and MMP tracer distribution was visualized repeatedly and non‐invasively by fluorescence reflectance imaging. In correlation with the presence of MMP‐2 and MMP‐9 in immunofluorescence stainings, Cy5.5‐AF443 accumulated in ICV spots in the skin of C57BL/6 mice. This tracer accumulation could also be observed in mice equipped with a dorsal skinfold chamber, where microscopic observations revealed an increased recruitment of fluorescence‐labelled leucocytes during ICV. The specificity of the MMP tracer was supported by (i) analysis of mice deficient in functional β2‐integrins (CD18?/?) and (ii) subsequent MMP immunofluorescence staining. These findings let us conclude that MMP accumulation in the acute phase of ICV depends on β2‐mediated leucocyte recruitment. In summary, we show that MMPs are involved in ICV as determined by Cy5.5‐AF443, a new optical marker to longitudinally and non‐invasively follow MMP activity in acute skin inflammation in vivo. 相似文献
107.
108.
109.
110.
Roman P. Jakob Gabriel Zoldák Tobias Aumüller Franz X. Schmid 《Proceedings of the National Academy of Sciences of the United States of America》2009,106(48):20282-20287
The cis/trans isomerization of peptide bonds before proline (prolyl bonds) is a rate-limiting step in many protein folding reactions, and it is used to switch between alternate functional states of folded proteins. Several prolyl isomerases of the FK506-binding protein family, such as trigger factor, SlyD, and FkpA, contain chaperone domains and are assumed to assist protein folding in vivo. The prolyl isomerase activity of FK506-binding proteins strongly depends on the nature of residue Xaa of the Xaa-Pro bond. We confirmed this in assays with a library of tetrapeptides in which position Xaa was occupied by all 20 aa. A high sequence specificity seems inconsistent with a generic function of prolyl isomerases in protein folding. Accordingly, we constructed a library of protein variants with all 20 aa at position Xaa before a rate-limiting cis proline and used it to investigate the performance of trigger factor and SlyD as catalysts of proline-limited folding. The efficiencies of both prolyl isomerases were higher than in the tetrapeptide assays, and, intriguingly, this high activity was almost independent of the nature of the residue before the proline. Apparently, the almost indiscriminate binding of the chaperone domain to the refolding protein chain overrides the inherently high sequence specificity of the prolyl isomerase site. The catalytic performance of these folding enzymes is thus determined by generic substrate recognition at the chaperone domain and efficient transfer to the active site in the prolyl isomerase domain. 相似文献